tirzepatide lawsuits Judge says compounding pharmacies must stop making copies of Zepbound, Mounjaro Zepbound Lawsuit | Individual and

Patients should understand the challenges around staying on medication, and that it is common for patients to stop

Alcohol is a stronger one

NICE guidance (NG28) recommends that patients starting GLP-1 receptor agonists like Ozempic should have: Baseline assessment including HbA1c, renal function, and body weight Regular monitoring of glycaemic control and tolerability Review at 6 months to assess treatment response (defined as HbA1c reduction of at least 11 mmol/mol and weight loss of at least 3% of initial body weight) Ongoing assessment of cardiovascular risk factors Patients with pre-existing conditions require particular consideration

Insulin as a bridge between type 2 diabetes and Alzheimer disease - how anti-diabetics could be a solution for dementia

Asia Pacific is projected to account for the fastest growth at a 15.3% CAGR